Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.01
Exchange
OTC Link
OS
BLACKHAWK GROWTH CRP
No one on the platform currently holds BLRZF.
No tracked institution reports a position in BLRZF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-12-18 | 1-for-10reverse |
| 2012-04-09 | 1-for-3reverse |
No one on the platform has traded BLRZF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BLRZFBlackhawk Growth Corp. | $0.01 | +0.00% | $97077 | — |
| AHFCFFlow Capital Corp. | $0.57 | -0.00% | $17M | — |
| FXBYFoxby Corp. | $23.50 | +0.00% | $12M | — |
| HCGIHuntwicke Capital Group Inc. | $6.15 | +0.00% | $16M | — |
| MATEFBlockmate Ventures Inc. | $0.03 | -0.83% | $4M | — |
| MONTFMontfort Capital Corp. | $0.00 | +0.00% | $306198 | — |
| PRPSPropellus Inc. | $2.89 | -0.21% | $26M | — |
Source: Financial Modeling Prep · peers by sector/industry
$BLRZF Multiple April news... by @thenewswire on 2 Apr 2025, 5:20 MindBio Adopts New Equity Incentive Plan by @thenewswire on 7 Apr 2025, 5:11 MindBio Issues Warrants to Haywood Securities by @thenewswire on 11 Apr 2025, 5:46 MindBio Therapeutics Corp. Announces Private Placement and Debt Settlements
View on StockTwits ↗$BLRZF https://www.accesswire.com/760258/MindBio-Therapeutics-Co-Founders-Appear-in-Leading-Australian-Financial-News-Publication-Ahead-of-Medicinal-Psychedelics-Legalisation-in-Australia
View on StockTwits ↗$BLRZF Blackhawk's Mindbio Reveals Positive Data From Phase 1 Randomised Double-Blind Placebo Controlled Clinical Trials Microdosing LSD In 80 Healthy Participants https://ceo.ca/@thenewswire/blackhawks-mindbio-reveals-positive-data-from-phase
View on StockTwits ↗$BLRZF Blackhawk's MindBio Therapeutics Announces Reveal Date for Presentation of Phase 1 Clinical Trial Data https://ceo.ca/@thenewswire/blackhawks-mindbio-therapeutics-announces-reveal-date MindBio Co-Founder Justin Hanka and scientific collaborators to present Phase 1 Microdosing LSD Clinical Trial data in Miami on November 4th 2022
View on StockTwits ↗$BLRZF - Blackhawk's Mindbio Therapeutics Accelerates Global Communications Expansion Ahead of Phase 2 Clinical Trials https://ceo.ca/@thenewswire/blackhawks-mindbio-therapeutics-accelerates-global
View on StockTwits ↗GOOD article: interesting perspectives and options of $BLRZF https://t.me/smallcapstockpickingcanada/125
View on StockTwits ↗$BLRZF Blackhawk Growth Fully Funds Phase II Clinical Trials in Psychedelics and Begins Development of Digital Mental Health Treatments https://ceo.ca/@thenewswire/blackhawk-growth-fully-funds-phase-ii-clinical-trials
View on StockTwits ↗$BLRZF Blackhawk Growth Completes Investment in California-Based Licensed Distribution Center - TERP Wholesale, LLC, Company Generated CAD$3,902,888 Revenue in 2020 https://ceo.ca/@thenewswire/blackhawk-growth-completes-investment-in-california-based
View on StockTwits ↗$BLRZF 👌 https://ceo.ca/@thenewswire/blackhawk-growths-mindbio-therapeutics-completes-safety
View on StockTwits ↗$BLRZF https://pro.ceo.ca/@thenewswire/blackhawk-growths-mindbio-therapeutics-looks-to-expand
View on StockTwits ↗$BLRZF https://www.thenewswire.com/press-releases/1BKRFeDK5-blackhawk-growths-mindbio-therapeutics-brings-digital-mental-health-technology-to-psychedelics-clinical-trials.html
View on StockTwits ↗$BLRZF https://www.thenewswire.com/press-releases?id=1A0vFPdly#news
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.